600420 国药现代
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.2596.9798.4686.0986.644
总资产报酬率 ROA (%)1.6114.8065.5143.5503.244
投入资产回报率 ROIC (%)2.0356.1957.3214.7704.527

边际利润分析
销售毛利率 (%)29.08532.42539.24438.32638.079
营业利润率 (%)9.51314.02916.0188.9617.455
息税前利润/营业总收入 (%)9.60213.76114.4868.4607.238
净利润/营业总收入 (%)7.70812.19912.1797.9926.694

收益指标分析
经营活动净收益/利润总额(%)82.92592.243103.30197.60193.010
价值变动净收益/利润总额(%)13.90010.0863.8322.5040.238
营业外收支净额/利润总额(%)-1.4761.060-4.7141.3621.827

偿债能力分析
流动比率 (X)3.4033.5912.6902.8202.785
速动比率 (X)2.7803.0322.1812.2162.203
资产负债率 (%)17.80717.59123.22025.90938.092
带息债务/全部投入资本 (%)8.9887.63811.28512.50627.277
股东权益/带息债务 (%)995.3081,187.934769.220688.287258.420
股东权益/负债合计 (%)398.552407.402284.958247.072137.817
利息保障倍数 (X)42.181-32.888-17.866-13.525-20.334

营运能力分析
应收账款周转天数 (天)50.27238.78538.78948.22258.162
存货周转天数 (天)127.771112.609121.599114.136123.644